ICON PLC
ICLR144.960USD
0.0000.00%
Cierre 04/25, 16:00（ET）Cotizaciones retrasadas 15 min
11.71BCap. mercado
14.79P/E TTM
Más Datos de ICON PLC Compañía
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Información de la empresa
Código de la empresaICLR
Nombre de la empresaICON PLC
Fecha de salida a bolsaMay 15, 1998
Fundada en1989
Director ejecutivoDr. Stephen (Steve) Cutler, Ph.D.
Número de empleados41900
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 15
DirecciónSouth County Business Park
CiudadDUBLIN
Bolsa de valoresNASDAQ Global Select Consolidated
PaísIreland
Código postal- -
Teléfono35312912000
Sitio Webhttps://www.iconplc.com/
Código de la empresaICLR
Fecha de salida a bolsaMay 15, 1998
Fundada en1989
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Barry Edward Balfe
Mr. Barry Edward Balfe
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Anne C. Whitaker
Ms. Anne C. Whitaker
Independent Director
Independent Director
--
--
Dr. Stephen (Steve) Cutler, Ph.D.
Dr. Stephen (Steve) Cutler, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Ronan Murphy
Mr. Ronan Murphy
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ciaran Murray
Mr. Ciaran Murray
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
20.00K
+3.40%
Dr. Linda S. Grais, M.D., J.D.
Dr. Linda S. Grais, M.D., J.D.
Independent Director
Independent Director
4.91K
+10.73%
Ms. Julie O'Neill
Ms. Julie O'Neill
Independent Director
Independent Director
2.37K
+22.58%
Mr. Eugene Mccague
Mr. Eugene Mccague
Independent Director
Independent Director
2.12K
+26.25%
Dr. John Climax
Dr. John Climax
Independent Director
Independent Director
--
--
Mr. Nigel Clerkin
Mr. Nigel Clerkin
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.99B
36.05%
Ireland
2.79B
33.73%
Rest of Europe
1.56B
18.85%
Rest of the World
942.64M
11.38%
Por negocio
Por región
Sin datos
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
WCM Investment Management
7.67%
Ninety One UK Limited
3.57%
MFS Investment Management
3.50%
Wellington Management Company, LLP
2.56%
ClearBridge Investments, LLC
2.49%
Other
80.21%
Estadísticas de accionistas
Accionista
Proporción
WCM Investment Management
7.67%
Ninety One UK Limited
3.57%
MFS Investment Management
3.50%
Wellington Management Company, LLP
2.56%
ClearBridge Investments, LLC
2.49%
Other
80.21%
Tipo
Accionista
Proporción
Investment Advisor/Hedge Fund
40.92%
Investment Advisor
38.63%
Hedge Fund
9.78%
Research Firm
2.93%
Pension Fund
2.80%
Bank and Trust
1.42%
Sovereign Wealth Fund
1.22%
Family Office
1.09%
Family Office
1.09%
Other
0.12%
Participación institucional
Hora de actualización: lun., 20 de ene
Hora de actualización: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1310
81.32M
98.50%
-4.92M
2024Q4
1334
80.88M
97.97%
-5.29M
2024Q3
1290
83.28M
100.86%
-2.02M
2024Q2
1273
83.12M
100.37%
-2.47M
2024Q1
1254
83.08M
100.49%
-3.81M
2023Q4
1237
84.94M
102.98%
-3.00M
2023Q3
1213
86.31M
104.85%
-1.65M
2023Q2
1199
85.95M
104.64%
+2.46M
2023Q1
1190
81.67M
99.73%
-2.49M
2022Q4
1181
81.26M
99.51%
-4.28M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
WCM Investment Management
6.33M
7.67%
-319.37K
-4.80%
Dec 31, 2024
Ninety One UK Limited
2.95M
3.57%
+250.55K
+9.29%
Dec 31, 2024
MFS Investment Management
2.89M
3.5%
-868.59K
-23.12%
Dec 31, 2024
Wellington Management Company, LLP
2.11M
2.56%
-968.73K
-31.43%
Dec 31, 2024
ClearBridge Investments, LLC
2.05M
2.49%
+555.48K
+37.12%
Dec 31, 2024
Templeton Investment Counsel, L.L.C.
1.88M
2.28%
+694.07K
+58.34%
Dec 31, 2024
Lazard Asset Management, L.L.C.
1.83M
2.22%
-525.85K
-22.28%
Dec 31, 2024
AllianceBernstein L.P.
1.82M
2.21%
+502.55K
+38.10%
Dec 31, 2024
T. Rowe Price International Ltd
1.62M
1.96%
+941.77K
+139.75%
Dec 31, 2024
Sustainable Growth Advisers, LP
1.59M
1.93%
+245.80K
+18.24%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
iShares MSCI Ireland ETF
15.67%
Polen Capital International Growth ETF
11.21%
Polen Capital Global Growth ETF
3.5%
VanEck Biotech ETF
3.39%
Motley Fool Global Opportunities ETF
3.07%
Janus Henderson US Sustainable Equity ETF
2.03%
Running Oak Efficient Growth ETF
1.58%
Harbor Health Care ETF
1.4%
Invesco ESG NASDAQ Next Gen 100 ETF
1.25%
Neuberger Berman Small-Mid Cap ETF
1.25%
Ver más
iShares MSCI Ireland ETF
Proporción15.67%
Polen Capital International Growth ETF
Proporción11.21%
Polen Capital Global Growth ETF
Proporción3.5%
VanEck Biotech ETF
Proporción3.39%
Motley Fool Global Opportunities ETF
Proporción3.07%
Janus Henderson US Sustainable Equity ETF
Proporción2.03%
Running Oak Efficient Growth ETF
Proporción1.58%
Harbor Health Care ETF
Proporción1.4%
Invesco ESG NASDAQ Next Gen 100 ETF
Proporción1.25%
Neuberger Berman Small-Mid Cap ETF
Proporción1.25%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos